Yayın:
Pharmacodynamic Comparison of a Nasal Formulation of Verapamil and Intravenous and Oral Dosage Forms

Sadeleştirilmiş öğe sayfası
dc.contributor.authorYazan, Yasemin
dc.contributor.authorA. Yekta Özer
dc.contributor.authorKevser Erol
dc.contributor.orcid0000-0002-5787-074X
dc.contributor.orcid0000-0002-8808-6616
dc.date.accessioned2025-11-13T20:52:37Z
dc.date.issued1996-01-01
dc.identifier.doihttps://doi.org/10.3109/03639049609058573
dc.identifier.endpage284
dc.identifier.issn0363-9045
dc.identifier.issue3
dc.identifier.openalexW2022775124
dc.identifier.startpage281
dc.identifier.urihttps://hdl.handle.net/11421/12851
dc.identifier.urihttps://doi.org/10.3109/03639049609058573
dc.identifier.volume22
dc.language.isoen
dc.relation.ispartofDrug Development and Industrial Pharmacy
dc.rightsrestrictedAccess
dc.subjectPharmacodynamics
dc.subjectVerapamil
dc.subjectBioavailability
dc.subjectPharmacology
dc.subjectOral administration
dc.subjectMedicine
dc.subjectDosage form
dc.subjectPharmacokinetics
dc.subjectPlacebo
dc.subjectFirst pass effect
dc.subjectDrug
dc.subjectRoute of administration
dc.subjectAnesthesia
dc.subjectInternal medicine
dc.subjectCalcium
dc.subject.sdg3
dc.titlePharmacodynamic Comparison of a Nasal Formulation of Verapamil and Intravenous and Oral Dosage Forms
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5005967372

Dosyalar

Koleksiyonlar

Publications